|
| Own Slots | ||
|---|---|---|
| Slot Name | Value | |
 |
Alternatives | |
|
CanImprove | |
|
CautionWithMedicationsUsed | |
|
Comment | |
|
Contraindication | |
|
CouldBeRelatedTo | |
|
Cui | C0116190 |
|
Definition | 1,3-Dihydro-4-methyl-5-(4-(methylthio)benzoyl)-2H-imidazol-2-one. A selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure. |
|
DespiteReceivingTreatment | |
|
DoNotUseWithMedicationGroup | |
|
EspeciallyEffectiveAgainst | |
|
Improves | |
|
Incrementsmgday | |
|
InitiatingDose | |
|
MaintenanceDose | (infusion) 1.25-7.5 ug/kg/min |
|
MaximumRecommendedDailyDose | |
|
MeanDailyDose | |
|
RelevantSignOrSymptom | |
|
SideEffect | Any_arrhythmia, Systolic_hypotension, Diastolic_hypotension |
|
Synonyms | |
|
TargetDose | (bolus) 0.25-0.75 mg/kg |
|
TitrationPeriod | |
|
TreatmentStatus | |
|
Treats | |
|
UMLSSynonyms | Fenoximone |
|
UsedTogetherWithMedication | |
|
UsedWithMedicationGroup | Adrenergic_beta-antagonists |
|
UseWhenExistsIntoleranceOf | |
|
UseWithTest |